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The cytogenetic abnormalities in non-small-cell lung cancer remain elusive due primarily to the difficulty in obtaining metaphase
spreads from solid tumours. We have used the molecular cytogenetic techniques of multicolour fluorescent in situ hybridisation
(M-FISH) and comparative genomic hybridisation (CGH) to analyse four primary non-small-cell lung cancer samples and two
established cell lines (COR-L23 and COR-L105) in order to identify common chromosomal aberrations. CGH revealed regions on
5p, 3q, 8q, 11q, 2q, 12p and 12q to be commonly over-represented and regions on 9p, 3p, 6q, 17p, 22q, 8p, 10p, 10q and 19p to be
commonly under-represented. M-FISH revealed numerous complex chromosomal rearrangements. Translocations between
chromosomes 5 and 14, 5 and 11 and 1 and 6 were observed in three of the six samples, with a further 14 translocations being
observed in two samples each. Loss of the Y chromosome and gains of chromosomes 20 and 5p were also frequent. Chromosomes
4, 5, 8, 11, 12 and 19 were most frequently involved in interchromosomal translocations. Further investigation of the recurrent
aberrations will be necessary to identify the specific breakpoints involved and any role they may have in the aetiology, diagnosis and
prognosis of non-small-cell lung cancer.
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Lung cancer is the biggest cause of cancer mortality in the world
and has one of the worst survival rates of any solid tumour.
Around 75–80% of all cases of lung cancer diagnosed are non-
small-cell lung cancer (NSCLC). Although our knowledge of the
events involved in NSCLC at the gene level is increasing, little is
known about the gross structural chromosomal changes involved
in the disease, in common with the majority of solid tumours. This
is due to the extreme difficulty in obtaining metaphase spreads of
sufficient quality and quantity for cytogenetic analysis. Interpreta-
tion of the complex genomes characteristic of solid tumours is also
technically difficult using conventional cytogenetic banding
methods. Conversely, studies of haematological malignancies have
identified specific chromosomal abnormalities that have proved to
be of diagnostic and prognostic value (Mitelman, 2000).
Recently developed molecular cytogenetic techniques have
increased the potential for karyotypic analysis of solid tumour
samples. Comparative genomic hybridisation (CGH) allows
screening of the entire genome in order to identify regions of
gain or loss of DNA and map them according to chromosomal
location (Kallioniemi et al, 1992). A major advantage of CGH is
that tissue culture and preparation of metaphase spreads is not
required as DNA extracted from a tumour specimen is used.
Previous CGH studies of NSCLC cell lines and primary tumours
have identified chromosomal regions that are commonly over- or
under-represented, including gains of 1q, 3q, 5p, 7p and 8q and
losses of 3p, 6q, 8p, 9p and 17p (Balsara et al, 1997; Petersen et al,
1997; Bjo ¨rkqvist et al, 1998; Speicher et al, 2000; Luk et al, 2001).
Multicolour fluorescent in situ hybridisation (M-FISH) is a
karyotyping technique that uses whole chromosome paints (WCP)
to label each chromosome a unique colour (Speicher et al, 1996).
Use of this technique facilitates the karyotyping of tumour cells
and allows the identification of marker chromosomes and complex
chromosomal rearrangements that would previously have been
uninterpretable. Additionally, the use of colour has opened up the
field to noncytogeneticists. Despite these technological advances,
acquisition of suitable metaphase spreads is still a problem and
consequently much of the work on solid tumours with M-FISH (or
the similar technique Spectral Karyotyping (SKY); Schro ¨ck et al,
1996) has been carried out using established cell lines. Although
useful models for studying cancer, our previous analysis of
independently cultured strains of a breast cancer cell line (Bahia
et al, 2002) revealed unique abnormalities in each variant,
suggesting that cell lines may not provide data as reliable and as
clinically relevant as that obtained from primary tumour samples.
To date, 10 NSCLC cell lines (MGH7, A549, A427, BEN, Colo699,
D51, D54, D97, D117 and DV-90) and just two primary tumour
samples (both squamous cell carcinomas) have been analysed
using M-FISH or SKY (Speicher et al, 2000; Gunawan et al, 2001;
Luk et al, 2001). These studies, and previous studies using
cytogenetic banding (Testa et al, 1994; Sundareshan and Augustus,
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s1996; Berker-Karau ¨zu ¨m et al, 1998) have revealed highly complex
cytogenetic changes in the majority of cases, with no common
pattern of chromosome rearrangements. Despite this, some
translocations have been reported by multiple authors: a t(3;19)
was observed in four studies and t(1;19) and t(1;16) in three
studies each (Sundareshan and Augustus, 1996; Speicher et al,
2000; Gunawan et al, 2001; Luk et al, 2001). Additionally,
isochromosomes of 5p and 8q are frequently observed in NSCLC
and are also seen in other solid tumours.
Here we present results from the analysis of four primary
NSCLC tumour samples in short-term culture and two established
NSCLC cell lines (COR-L23 and COR-L105) by M-FISH and CGH.
To our knowledge, the karyotypes of these two cell lines have not
previously been reported. The aim of our study was to examine the
gross genomic changes present in order to identify structural and
numerical alterations that may warrant further investigation using
higher resolution molecular techniques. It is hoped that the
identification of such changes may eventually lead to improve-
ments in diagnosis and the identification of prognostic factors for
NSCLC.
MATERIALS AND METHODS
Primary tumour samples
Samples of fresh lung tumour were obtained from patients
undergoing surgery for NSCLC at Castle Hill Hospital. Informed
consent was obtained from all patients and local ethical approval
granted for the study. All tumour samples were processed on the
day of surgery. Tissue samples were cut into pieces approximately
1mm
3 using sterile scalpels and a cell suspension obtained by
digestion with 0.5mgml
 1 type III collagenase (Sigma-Aldrich,
Dorset, UK) at 37
1C with 5% CO2 for 18–24h. Cells were pelleted
at 200g for 4min and resuspended in RPMI 1640 medium
supplemented with 10% vv
 1 foetal calf serum, 2mM glutamine,
100Uml
 1 penicillin, 100mgml
 1 streptomycin and 2.5mgml
 1
fungizone (Life Technologies, Paisley, UK) and the suspension was
transferred to 25cm
2 tissue culture flasks and incubated at 371C
with 5% CO2. Once cells began to grow in the flasks, the RPMI
medium was changed for ACL-4 (Masuda et al, 1991). Flasks were
monitored each day for cell growth and the medium changed as
required (at least once a week). Characteristics of the primary
tumour samples are given in Table 1.
NSCLC cell lines
Two established NSCLC cell lines were acquired from the
European Collection of Cell Cultures (ECACC, Wiltshire, UK)
and were fully authenticated prior to distribution. The cell lines
were COR-L23 (ECACC No. 92031919; Baillie-Johnson et al, 1985),
a large cell carcinoma, and COR-L105 (ECACC No. 92031918), an
adenocarcinoma, both established from pleural effusions from
Caucasian males. Cell lines were cultured in RPMI 1640 medium
supplemented with 10% vv
 1 foetal calf serum, glutamine,
penicillin, streptomycin and fungizone (as above).
Preparation of metaphase spreads
Cell cultures were treated with colcemid (Life Technologies) prior
to reaching confluence and incubated at 371C. Cell lines received
200ml1 0 mgml
 1 colcemid for 1h; treatment conditions for
primary tumour samples are given in Table 1. Cells were harvested
and treated with hypotonic solution (0.075 M KCl) for 20min, fixed
in three changes of fixative solution (3:1, methanol:acetic acid)
and stored at  201C overnight. Chromosome preparations were
dropped onto cleaned, humidified standard microscope slides and
stored overnight at room temperature. Slides were assessed using
phase contrast microscopy to ensure the presence of metaphase
spreads of suitable quality before performing M-FISH.
M-FISH
M-FISH was performed as described previously (Ashman et al,
2002; Bahia et al, 2002) using the SpectraVysiont Assay system
(Abbott Laboratories, Maidenhead, UK). SpectraVysion consists of
a 52-probe mix of WCPs labelled with different combinations of
five fluorochromes (SpectrumGold, SpectrumRed, SpectrumGreen,
SpectrumAqua and SpectrumFarRed). In total, 24 combinations of
no more than three fluorochromes are used, resulting in a unique
colour for each chromosome (22 autosomes and two sex
chromosomes).
Before the probe was applied, metaphase preparations were
enzymatically treated with RNase and pepsin to remove RNA
molecules and cytoplasmic proteins. Exact conditions varied
between preparations depending on the amount of residual
cytoplasm. Slides were fixed in a 1% formaldehyde solution,
dehydrated, denatured in 70% formamide/2  saline sodium
citrate (SSC) and dehydrated for a second time. A measure of 10ml
of SpectraVysion probe was denatured, applied to the slides and
incubated at 371C for 72h to allow the probe to hybridise to the
chromosomes. Following hybridisation, slides were washed in
0.4  SSC/0.3% NP-40 (Abbott) at 721C for 2min followed by 2 
SSC/0.1% NP-40 at room temperature for 30s. Slides were air dried
and counterstained with 10mlo f4 2 n g m l
 1 4,6-diamidino-2-
phenylindole (DAPI) counterstain in antifade (Abbott).
Images of metaphase spreads were captured using a Nikon
s
E800 epifluorescent microscope equipped with a Ludl 6 position
filter wheel and a Photometrics Sensyst cooled charge coupled
device (CCD) camera. Six images were captured using filter
combinations specific for each of the five fluorochromes and
DAPI. All metaphases of suitable quality for analysis were
captured. Spreads ideally contained long, well spread out
chromosomes and did not contain large amounts of cell debris.
Images were analysed using the Quips SpectraVysion software
(Abbott) by examining each individual colour plane (Red, Gold,
Green, Aqua and Far Red) and identifying the chromosomal
material present by the combinations of fluorochromes observed.
The analysis of a primary squamous cell carcinoma is shown in
Figure 1.
A composite karyotype was compiled for each sample using six
to nine metaphase spreads. Following ISCN recommendations
(ISCN 1995), rearranged chromosomes were included when two or
more cells exhibited the same structural aberration. The modal
number of each whole or rearranged chromosome was used in the
composite karyotype. Translocations were reported in shortened
ISCN format as derivative (der) chromosomes, but the break
points could not be defined as identification using DAPI banding
is difficult and requires cytogenetic expertise. Inversions and small
deletions or amplifications are not identifiable using M-FISH.
Table 1 Characteristics and colcemid treatment conditions of the four
primary NSCLC samples
SCC-1 SCC-2 AC-1 AC-2
Sex Male Male Female Male
Age (years) 71 76 53 69
Cancer site LUL RUL RUL LUL
Culture time 79 days 3 days 62 days 20 days
Colcemid 10ml,
10mgml
 1
100ml,
1mgml
 1
200ml,
10mgml
 1
150ml,
1mgml
 1
Treatment 16h 16h 3h 16h
SCC¼squamous cell carcinoma; AC¼adenocarcinoma; LUL¼left upper lobe;
RUL¼right upper lobe.
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All CGH reagents were obtained from Abbott Laboratories and
experiments were performed as described previously (Stafford et al,
1999). Briefly, 400ng tumour DNA labelled with SpectrumGreen
was combined with 200ng reference DNA labelled with Spec-
trumRed and 20mg of Cot-1 blocking DNA. This probe mix was
ethanol precipitated, resuspended in hybridisation buffer and
hybridised to normal human metaphase chromosomes for 72h
at 371C. Slides were washed in 0.4  SSC/0.3% NP-40 followed
by 2  SSC/0.1% NP-40, air dried, and counterstained with
125ngml
 1 DAPI in antifade. In total, 10 images of metaphase
spreads were captured per sample using the same system as for
M-FISH and analysed using the Quips CGH Analysis software
(Abbott). Losses and gains of DNA sequences were scored
whenever the ratio of red:green or green:red fluorescence
exceeded thresholds established through hybridisations of differ-
ently labelled normal DNA samples (0.85 and 1.15, respectively).
RESULTS
M-FISH
The composite karyotype for each sample analysed by M-FISH (see
Figure 1) is shown in Table 2. In total, 93 different interchromo-
somal translocations were observed in the composite karyotypes
from the six samples and 17 of these were observed in more than
one sample: 14 in two samples and three in three samples (Table 3).
Every chromosome was involved in at least one translocation, but
six chromosomes (4, 5, 8, 11, 12 and 19) appeared to be involved
particularly frequently (Figure 2). Chromosome 5 was the most
frequently involved chromosome, with 38 translocations. Struc-
tures believed to be isochromosomes of 5p were observed in three
samples and of 6p and 13q in one sample each.
Primary tumour samples had very complex karyotypes with
many structural aberrations, whereas the two cell lines, especially
COR-L23, were less complex and harboured only a few transloca-
tions (two in COR-L23 and 15 in COR-L105, compared with a
mean of 32 in the primary tumour samples).
Numerical abnormalities were difficult to identify due to the
complexity of the karyotypes and the involvement of the same
chromosome in multiple rearrangements within a single karyo-
type. However, some recurrent numerical changes of whole
chromosomes or chromosome arms were observed: a gain of
chromosome 20 (above the ploidy level of the sample) in three
samples, additional copies of 5p in two samples (some in the form
of 5p isochromosomes), loss of the Y chromosome in three of the
five male samples and deletions of 3p in two samples.
CGH
CGH data for five of the six samples (AC-1, AC-2, SCC-2, COR-L23
and COR-L105) were available. The most common areas of loss
and gain of DNA sequences and minimal regions of overlap are
shown in Table 4. Other regions of interest include 14q and 15q,
where gains were seen in the two cell lines but not in any of the
primary tumour samples (data not shown). The X and Y
chromosomes were excluded from CGH analysis as samples and
reference DNA were not sex-matched.
DISCUSSION
There is little known about the gross chromosomal aberrations
present in solid tumours, mainly due to the difficulty in obtaining
metaphase spreads from such samples and the complex nature of
the karyotypes, which makes analysis by banding patterns
incredibly difficult. We have analysed four primary NSCLC
tumours and two established NSCLC cell lines using modern
molecular cytogenetic techniques that allow genetic aberrations to
be elucidated, which would have been uninterpretable using
conventional cytogenetic methods.
The karyotypes of the primary tumour samples were highly
complex and contained many structural aberrations, including the
involvement of some chromosomes in many different rearrange-
ments within a single karyotype. The established cell lines showed
generally less complex karyotypes, but structural alterations were
still present. In total, 93 different interchromosomal translocations
were observed in the six samples. Due to the genetic instability of
cancer cells, many of these could merely be random rearrange-
ments of unstable genetic material. However, 17 translocations
were observed in either two or three samples, suggesting that
combinations of specific chromosomes may occur nonrandomly.
Figure 1 Analysis of a primary squamous cell carcinoma (SCC-1) by M-
FISH: the metaphase spread stained with DAPI (A) and the M-FISH probe
(B), an example of a translocation involving material originating from
chromosomes 10, 2 and 11 (C) and the karyotype of the cell (D). The
chromosome view shows (from left to right): the chromosome as it
appears in the metaphase spread, the pseudocolours generated by the
computer, a graph of the intensity of each fluorochrome along the
chromosome axis, the individual colour planes (red, gold, green, aqua and
far red), the composite image of all the colours and the chromosome
stained with DAPI. This metaphase contains 51 chromosomes and is one of
the seven spreads used in compiling the composite karyotype of the sample
(see Table 2).
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and t(8;19) have been reported by other authors (Gunawan et al,
2001; Speicher et al, 2000). Those translocations appearing in three
samples are of particular interest, especially t(5;14), as this
rearrangement was observed in three primary tumour samples,
rather than in the established cell lines. In a recent study using M-
FISH, Gunawan et al (2001) recorded the presence of two
derivative chromosomes formed by a t(5;14) translocation in a
primary squamous cell carcinoma. Two of the three samples in
which we observed this translocation were also squamous cell
carcinomas, although the samples size is far too small to be able to
speculate as to whether this may be a histotype-related change.
Gunawan et al (2001) also report a t(5;11) translocation, another of
the rearrangements to be identified in three samples in this study.
The remaining frequent translocation observed in our study, t(1;6),
has also previously been reported by two authors (Luk et al, 2001;
Speicher et al, 2000). Despite the small numbers of samples
involved, the fact that these combinations of chromosomes have
been reported in more than one study may imply that they could
be important in the development of NSCLC. It is not possible to
say whether the breakpoints involved in these common transloca-
tions are the same in each case. Further investigation of the
chromosomes involved will be necessary to ascertain if this is so,
and if specific genes located at the breakpoints are perturbed by
the rearrangements.
Six chromosomes (4, 5, 8, 11, 12 and 19) were shown to be
involved in rearrangements more often than the other chromo-
somes. Chromosome 5 was involved particularly frequently,
with 38 interchromosomal translocations. In addition, the
p-arm of this chromosome was the most frequently gained region
as indicated by CGH. The possible formation of 5p isochromo-
somes observed by M-FISH is supported by the CGH data, as the
two samples harbouring iso 5p for which CGH data are available
show a gain of the entire p-arm. Formation of 5p isochromosomes
would also require rearrangement of chromosome 5 material,
thus further increasing the number of rearrangements involving
this chromosome. Speicher et al (2000) reported frequent
involvement of chromosomes 1, 2, 3, 11, 12 and 22 in intra-
and interchromosomal changes. Chromosomes 5, 8 and 19
were observed by these authors to be involved less frequently,
and chromosome 4 was involved infrequently in rearrangements.
Our data therefore partially support those of Speicher et al
(2000), and suggest that in addition to chromosome 5, chromo-
somes 11 and 12 may be of particular interest. The differences
between the two studies may represent true differences between
the tumours and cell lines analysed or may be a reflection
of the small sample sizes used. This would only be resolved
by a larger scale study. Although not all of the frequently
rearranged chromosomes have been observed to participate in
specific fusions with other chromosomes, the breakpoints involved
warrant further investigation to discover if the same loci are
involved each time.
The observation of 5p isochromosomes supports previous
reports (Testa et al, 1994; Speicher et al, 2000; Luk et al, 2001).
Polysomy of chromosome 20 has also been observed previously
in NSCLC (Testa et al, 1994; Berker-Karau ¨zu ¨m et al, 1998), and
loss of the Y chromosome in males is known to be common in
tumour cells.
Table 2 Composite karyotype for each tumour sample and cell line
Sample Composite karyotype
SCC-1 # 48–57 1 2, der(1)t(1;X;6), 2 2, der(2)t(10;2;11), 3 2, der(3)t(3;10), 4, der(?)t(4;13) 2 (two different translocations), 5 2, del(5?q),
der(?)t(5;22), ?i(5p), 6 2, der(6)t(1;6), 7 2, der(7)t(7;12), der(?)t(7;12), 8, der(8)t(Y;8), 9 2, der(10)t(5;10), 11, der(?11)t(11;16;11), 12 2,
13 2, 14 2, der(14)t(5;14), 15 2, 16 2, 17 2, 18 2, 19 2, 20 4, ?i(21q), 22, der(X)t(X;11), der(X)t(X;12;7;1) [cp7]
SCC-2 # 37–48 1 2, ?del(2p), der(2)t(2;9), ?del(3p) 2, 4, der(4)t(4;5), 5, ?i(5p), 6, 7 2, 8, der(8)t(8;11), 9, der(9)t(5;9), 10, der(10)t(8;10;3), 11,
der(?11)t(11;5;12;7), der(?11)t(11;5;14), der(11)t(11;18), 12, der(12), 13, i(13q), 14, der(14)t(14;18), 15 2, 16, der(16)t(16;19), ?del(17p) 2, 18,
der(?18)t(18;11;8;6), der(?18)t(6;18) 2, 19, der(19)t(8;19), 20 2, 21 2, 22, der(22)t(5;22;1), X, Y [cp8]
AC-1 ~ 70–90 1 4, der(1)t(1;9), 2 2, der(2)t(20;6;2) 2, der(2)t(2;5), der(2)t(2;3), der(2)t(2;4), 3 3, der(3)t(3;9), der(3)t(3;16), 4 2, der(4)t(4;12),
der(4)t(4,13), 5 2, der(5)t(5;6), der(5)t(5;17), 6 3, der(6)t(6;11) 2, 7 3, der(7)t(7;18) 2, der(7)t(7;22) 2, 8 2, der(8)t(13;8;13) 2, 9,
der(9)t(9;14;11) 3, der(9)t(9;14) 2, 11 4, 12 3, der(12)t(4;12), 14, der(15)t(5;15), der(15)t(15;17) 2, der(16)t(16;21) 2, 17,
der(17)t(10;17), 18 2, 19 4, 20 4, der(21)t(5;21), 22 2, der(22)t(22;18;22;18), X, der(X)t(X;4) [cp6]
AC-2 # 24–47 1, der(?1)t(1;12;2), der(?1)t(6;1;14;5), der(2)t(7;2;21), der(2)t(2;15), 3, del(3p), der(3), der(4)t(4;10), der(4)t(5;19;5;19;4;5;11),
der(4)t(7;19;5;19;4;6;5;11), der(5)t(5;17), der(6)t(1;6), der(6)t(6;15), i(6p), der(8)t(1;8), der(8)t(5;8), der(8)t(8;12), der(9)t(4;9), der(9)t(7;9),
der(9)t(9;17), 10, der(10)t(10;15), der(10)t(10;19;17), der(11)t(5;11), der(12)t(12;8;12;5;19;11;19), der(12)t(3;12), der(15)t(8;15), 16,
der(16)t(19;5;12;5;16;4;19;5;19;7), 17, 18, der(19)t(8;19), 20 3, der(?21)t(12;21), der(22)t(3;22), der(22)t(14;22), der(X)t(3;X), der(X)t(5;X)
[cp6]
COR-L105 (AC) # 18–39 der(1)t(1; 11), der(1)t(1;6), 2 2, der(3)t(3;21), der(3)t(3;X;4;X), 4, 5, 6, 7, der(7)t(7;10), 8, 9, 10, der(10)t(7;10), der(11)t(5;11), 12,
13, 14, der(14)t(8;14), der(14)t(12;14), 15, der(15)t(15;12;8), 16, der(16)t(3;16), 17, 18, 19, der(19)t(16;19), 20, 21, 22 [cp9]
COR-L23 (LCC) # 97–105 l 4, 2 4, 3 4, der(3), der(3)t(1;3), 4 4, 5 4, ?i(5p) 2, 6 4, 7 4, 8 6, 9 4, 10 4, 11 6, 12 5, 13 4, 14 6, 15 4,
16 6, 17 4, 18 4, 19 4, 20 6, 21 4, 22 4, X 2, der(X)t(X;15) 2 [cp6]
Bold numbers at the beginning of each karyotype are the range of chromosome numbers for the spreads analysed, numbers in square brackets are the number of spreads used
to compile the composite karyotype. The number of each chromosome or altered chromosome given is the modal number. Bold text represents translocations that may be
reciprocal.
Table 3 17 translocations that were observed in more than one sample
by M-FISH and the number of times they were observed primary tumours
and cell lines
Translocation
Primary tumour
(n¼4)
Cell line
(n¼2)
Total
(n¼6)
t(5;14) 3
a 03
t(1;6) 2 1 3
t(5;11) 2 1 3
t(3;10) 2
a 02
t(5;22) 2
a 02
t(7;12) 2
a 02
t(5;6) 2
b 02
t(5;17) 2
b 02
t(4;5) 2 0 2
t(4;13) 2 0 2
t(5;12) 2 0 2
t(8;19) 2 0 2
t(X;3) 1 1 2
t(X;4) 1 1 2
t(3;16) 1 1 2
t(8;12) 1 1 2
t(16;19) 1 1 2
aTwo squamous cell carcinoma samples.
bTwo adenocarcinoma samples.
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frequently gained are consistent with published results. Chromo-
some arms 3q, 5p and 8q, along with 1q and 7p, have been
shown to be commonly over-represented in NSCLC. The minimal
region of overlap on 8q in our study (q23) is the location
of the EBAG9/RCAS1 gene, which encodes a cancer cell-surface
antigen implicated in immune escape and has recently been
shown to be amplified in breast cancer (Tsuneizumi et al, 2001).
A potentially important gene located within the minimal region
of overlap on 5p (p11-p13) is SKP2 at 5p13. This proto-
oncogene encodes a protein which is associated with the
cyclinA/cdk2 complex and is essential for transition into S-phase
(Zhang et al, 1995). The minimal region of overlap observed
on 11q (q13) is the site of the cyclin D1 gene which is an oncogene
implicated in lung cancer. Gains of 11q have previously
been reported in NSCLC by Petersen et al. (1997) and Luk et al.
(2001). The final region gained in four samples was 3q (minimal
region of overlap q13.3–q25). Gains of 3q have previously been
shown to be important in lung cancer, especially 3q25–q27
in squamous cell carcinoma, suggesting that multiple genes within
this region may be important for tumorigenesis (Kettunen et al,
2000).
The observation of losses on chromosomes 3p, 6q, 9p and 17p is
also in agreement with the current body of literature relating to
NSCLC (Balsara et al, 1997; Petersen et al, 1997; Bjo ¨rkqvist et al,
1998; Speicher et al, 2000; Luk et al, 2001). Losses of all these
regions were observed in either four or five samples in this study.
Chromosomes 9p and 17p are known to harbour the tumour
suppressor genes p16 and p53, respectively, but their locations do
not correspond to the minimal regions of overlap identified in this
study. Losses of 3p, including 3p25, are known to be frequent in
lung cancer. The minimal region of loss observed here (3p24–p25)
is in agreement with this. Potentially important genes within this
region are retinoic acid receptor beta (RARB) at 3p24, which is a
nuclear transcription factor thought to limit cell growth by
regulating gene expression, and the von Hippel-Lindau (VHL)
tumour suppressor gene at 3p25. Losses of 3p and 6q have
previously been associated with the metastatic phenotype in
both adenocarcinoma and squamous cell carcinoma of the
lung (Petersen et al, 2000; Goeze et al, 2002). A further region
found to be frequently lost in this study was 22q, with the minimal
region of overlap at q13. The existence of putative tumour
suppressor gene(s) in this region involved in breast and colorectal
tumorigenesis has been proposed (Castells et al, 2000), but to our
knowledge this has not previously been characterised in lung
cancer.
In summary, we have demonstrated the power of M-FISH, in
combination with CGH, in the study of primary NSCLC and
established cell lines. The use of this colour-karyotyping technique
has enabled the highly complex genomes of these samples to be
analysed in far greater detail than would previously have been
possible. Despite the small sample size, we have been able to
identify certain chromosomes and chromosomal regions which are
frequently involved in structural and numerical aberrations and
which may therefore warrant further investigation. The use of
higher resolution molecular genetic techniques will enable the
specific breakpoints and genes involved in these aberrations to be
identified. This in turn is likely to lead to an increased
understanding of the aetiology and progression of NSCLC and
yield information that can be used to improve patient diagnosis
and prognosis.
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Figure 2 Graphical representation of the total number of interchromosomal translocations for each chromosome observed in the composite karyotypes
for four primary NSCLC samples and two cell lines. The dashed line indicates an arbitary cutoff between the six chromosomes, which appear to be
frequently involved in translocations and those which are involved less often.
Table 4 Common regions of gain and loss of DNA sequences (including
minimal regions of overlap) in primary tumour samples and cell lines
observed by CGH
Region
Primary
tumour
(n¼3)
Cell line
(n¼2)
Total
(n¼5)
Minimal region
of overlap
Gain
5p 3 2 5 p11–p13
a
3q 2 2 4 q13.3–q25
8q 2 2 4 q23
11q 2 2 4 q13
2q 2 1 3 q22–q24
12p 1 2 3 p11.1–p11.2
12q 1 2 3 q21
Loss
9p 3 2 5 p23
3p 2 2 4 p24–p25
6q 2 2 4 q25–qter
17p 2 2 4 p11.1–p12
22q 2 2 4 q13
8p 2 1 3 p21–p22
10p 2 1 3 p13
10q 2 1 3 q25–qter
19p 2 1 3 p13.2
aFour out of five samples (including two observed by M-FISH to have iso5p) showed
gains of the entire 5p arm.
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